Trial Profile
A trial to assess an extra-fine, inhaled formulation of beclomethasone/formoterol in patients with asthma switched from treatment with fluticasone/salmetrol or budesonide/formoterol
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2014
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 22 Sep 2014 New trial record